Multidrug resistant Vibrio cholerae O1 from clinical and environmental samples in Kathmandu city

BMC Infectious Diseases

Volumn 15, Issue 1, 2015, Pages

  Thapa Shrestha, Upendra ^a,b   Adhikari, Nabaraj ^b   Maharjan, Rojina ^b   Banjara, Megha R ^c   Rijal, Komal R ^c   Basnyat, Shital R ^b   Agrawal, Vishwanath P ^a  

^a Research Laboratory for Biotechnology and Biochemistry RLABB   (Nepal)

^b Kantipur College of Medical Science (KCMS) Department of Microbiology   (Nepal)

^c TRIBHUVAN UNIVERSITY   (Nepal)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFOTAXIME; CHLORAMPHENICOL; COTRIMOXAZOLE; ERYTHROMYCIN; NALIDIXIC ACID; TETRACYCLINE; ANTIINFECTIVE AGENT; CHOLERA TOXIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BIOTYPE; CONTROLLED STUDY; CTX GENE; CTXA2 GENE; CTXB GENE; DISK DIFFUSION; FECES ANALYSIS; GENETIC SCREENING; MULTIDRUG RESISTANCE; NEPAL; NONHUMAN; POLYMERASE CHAIN REACTION; SEROTYPING; VIBRIO CHOLERAE; WATER SAMPLING; ADULT; CHOLERA; CITY; CLASSIFICATION; CROSS INFECTION; ENVIRONMENT; EPIDEMIC; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PROCEDURES; VIBRIO CHOLERAE O1; YOUNG ADULT;

ADULT; ANTI-BACTERIAL AGENTS; CHOLERA; CHOLERA TOXIN; CITIES; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENVIRONMENT; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NEPAL; POLYMERASE CHAIN REACTION; SEROTYPING; VIBRIO CHOLERAE O1; YOUNG ADULT;

EID: 84928709725     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-015-0844-9     Document Type: Article

References (45)

1. Bryce J, Boschi-Pinto C, Shibuya K, Black RE, the WHO Child Health Epidemiology Reference Group. WHO estimates of the causes of death in children. Lancet. 2005;365:1147-52.
2. Harris JB, LaRocque RC, Qadri F, Ryan ET, Calderwood SB. Cholera. Lancet. 2012;379:2466-76.
3. + El Tor carrying an additional truncated CTX Prophage. Proc Natl Acad Sci U S A. 2014;111(27):9917-22.
4. Chatterjee SN, Chaudhuli K. Lipopolysaccharides of Vibrio cholerae. I. Physical and Chemical Characterization. Biochim Biophys Acta. 2003;1639:65-79.
5. Ramamurthy T, Nair GB. Evolving identity of epidemic Vibrio cholerae past and present. Sci Cult. 2010;76:153-9.
6. Kaper JB, Morris JG, Levine MM. Cholera. Clin Microbiol Rev. 1995;8:48-86.
7. Yi Y, Lu N, Liu F, Li J, Zhang R, Jia L, et al. Genome sequence and comparative analysis of a Vibrio cholerae O139 strain E306 isolated from a cholera case in China. Gut Pathogens. 2014;6:3.
8. Dixit SM, Johura FT, Manandhar S, Sadique A, Rajbhandari RM, Mannan SB, Rashid M, Islam S, Karmacharya D, Watanabe H, Sack RB, Cravioto A, Alam M: Cholera outbreaks (2012) in three districts of Nepal reveal clonal transmission of multi-drug resistant Vibrio cholerae O1. BMC Infectious Diseases, 2014, 14:392, http://www.biomedcentral.com/1471-2334/14/392 .
9. Pun SR, Maharjan R, Shrestha D, Pokharel D, Shah Y, Bastola A, et al. An outbreak of Vibrio cholerae in 2012, Kathmandu. Nepal Trop Med Surg. 2013;1:115. doi: 10.4172/tpms. 1000115 .
10. Shrestha UT, Sujakhu H. Coliform and Vibrio cholerae analysis of drinking water collected from cholera outbreak region of Bhaktapur Municipality. International Journal of Environment. 2014;3(3):139-45.
11. Sanchez J, Holmgren J. Cholera toxin- afoe & a friend. Indian J Med Res. 2011;133:153-63.
12. Maheshari M, Nelapati K, Kiranmayi B. Vibrio cholerae-A Review. Veterinary world. 2011;4(9):423-8.
13. Garg P, Chakraborty S, Basu I, Datta S, Rajendran K, Bhattacharya T, et al. Expanding multiple antibiotic resistance among clinical strains of Vibrio cholerae isolated from 1992-7 in Calcutta, India. Epidemiol Infect. 2000;124:393-9.
14. World Health Organization, WHO Bulletin, Drug-resistant Salmonella, Available http://www.who.int/ mediacentre/factsheets/fs139/en. Accessed March 20, 2009.
15. Vila J, Pal T. Update on antibacterial resistance in low-income countries factors favoring the emergence of resistance. The Open Infectious Diseases Journal. 2010;4:38-54.
16. Forbes BA, Sahm DF, Weissfeild AS, Bailey WR. Bailey and Scotts' Diagnostic Microbiology (Eds. Forbes BA, Sahm DF, Weissfeild AS). 12th edn, Elsevier Mosby Publisher, 2007, Original from The University of Michigan, pp-105-119, 371-379, ISBN-0323030653, 9780323030656
17. CLSI- Clinical Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing; twenty second informational supplement, 32:M100-S22. 2012.
18. Ranjbar R, Pourshafie MR, Sadeghifard N, Karami A, Hamidian M, Izadi M, et al. Molecular Characterization of Epidemic Isolates of Vibrio cholerae O1 by Arbitrarily primed PCR (AP-PCR). Iranian J Publ Health. 2008;37(2):83-7.
19. Patrick GB, Nishibuchi M, Tunung R, Son R. Molecular characterization of clinical isolate of Vibrio cholerae isolated from outbreaks cases in Malaysia. International Food Research Journal. 2012;19(3):1267-74.
20. Karki A, Tiwari BR. Prevalence of acute diarrhea in Kathmandu valley. J Nepal Med Assoc. 2007;46:175-9.
21. Tamang MD, Sharma N, Makaju RK, Sarma AN, Koju R, Nepali N, et al. An outbreak of El Tor cholera in Kavre district, Nepal. Kathmandu Univ Med J. 2005;3:138-42.
22. Kansakar P, Baral P, Malla S, Ghimire GR. Antimicrobial susceptibilities of enteric bacterial pathogens isolated in Kathmandu, Nepal, during 2002-2004. J Infect Dev Ctries. 2011;5:163-8.
23. Karki R, Bhatta DR, Malla S, Dumre SP. Cholera incidence among patients with diarrhea visiting National public health laboratory, Nepal. Jpn J Infect Dis. 2010;63:185-7.
24. Shah BK, Sharma S, Shakya G, Upadhyay BP. Multiple drug resistant Vibrio cholerae, Salmonella and Shigella from Nepalgunj Cholera outbreak and different hospitals of Nepal. Nepalese Journal of Biosciences. 2012;2:31-9.
25. Malla S, Kansakar P, Ghimirey G. Cholera outbreak in Kathmandu valley in 2004: A review of National Public Health Laboratory findings. J Nepal assoc Med Lab Sciences. 2005;7:20-3.
26. Faruque SM, Albert MJ, Mekalanos JJ. Epidemiology, Genetics, and Ecology of Toxigenic Vibrio cholerae. Microbiol Mol Biol Rev. 1998;62:1301-14.
27. Pokharel M, Sherchand JB, Upreti HC, Katuwal A, Gauchan P. A perspective study on the etiology of diarrhea in children less than 12 years of age attending Kanti Children's Hospital. J Nepal Paediat Soc. 2009;29:10-6.
28. Sherchand JB, Yokoo M, Sherchand O, Pant AR, Nakagom O. Burden of enteropathogens associated diarrheal diseases in children hospital. Nepal Scientific World. 2009;7:71-5.
29. Shrestha SD, Malla S, Adhikari BR, Shakya G, Basnyat SR, Sharma S. Antibiotic susceptibility patterns of Vibrio cholerae isolates. J Nepal Med Assoc. 2010;49(179):232-6.
30. Rai SK, Bhatta DR. Study of enteropathogens and its predisposing factors in gastroenteritis suspected children attending Kanti Children Hospital, Kathmandu, Nepal. J Nepal Asso Med Lab Sciences. 2004;6:48-53.
31. Taneja N, Mohan B, Khurana S, Sharma M. Antimicrobial resistance in selected bacterial enteropathogens in north India. Indian J Med Res. 2004;120:39-43.
32. Yadav DK, Tamrakar D, Baral R, Jha P, Gautam S, Pokharel PK. Outbreak of Cholera in Tilathi VDC Saptari Nepal. Kathmandu Univ Med J. 2012;10:36-9.
33. Das S, Choudhry S, Saha R, Ramachandran VG, Kaur K, Sarkar BL. Emergence of multiple drug resistance Vibrio cholerae O1 in East Delhi. J Infect Dev Ctries. 2011;5:294-8.
34. Goel AK, Jiang SC. Genetic determinants of virulence, antibiogram and altered biotype among the Vibrio cholerae O1 isolates from different cholera outbreaks in India. Infect Genet Evol. 2010;10:814-8.
35. Mandomando I, Espasa M, Valles X, Sacarlal J, Sigauque B, Ruiz J, et al. Antimicrobial resistance of Vibrio cholerae O1 serotype Ogawa isolated in Manhica District Hospital, southern Mozambique. J Antimicrob Chemother. 2007;60:662-4.
36. Garg P, Sinha S, Chakraborty R, Bhattacharya SK, Nair GB, Ramamurthy T, et al. Emergence of fluoroquinolone-resistant strains of Vibrio cholerae O1 biotype El Tor among hospitalized patients with cholera in Calcutta, India. Antimicrob Agents Chemother. 2001;45:1605-6.
37. Mukhopadhyay AK, Basu I, Bhattacharya SK, Bhattacharya MK, Nair GB. Emergence of fluoroquinolone resistance in strains of Vibrio cholerae isolated from hospitalized patients with acute diarrhea in Calcutta, India. Antimicrob Agents Chemother. 1998;42:206-7.
38. Sharifi-Mood B, Metanat M. Diagnosis, Clinical Management, Prevention, and Control of Cholera. A Review Study Int J Infect. 2014;1(1):e18303.
39. Shah M, Faruque M, Islam J, Ahmad QS, Biswas K, Faruque ASG. An improved technique for isolation of environmental Vibrio cholerae with epidemic potential: monitoring the emergence of a multiple-antibiotic-resistant epidemic strain in Bangladesh. J Infect Dis. 2006;193:1029-36.
40. Siddique AK, Baqui HA, Eusof A, Haider K, Hossain MA, Bashir I, et al. Survival of classic cholera in Bangladesh. Lancet. 1991;337:1125-7.
41. Mandal S, Mandal MD, Kumar Pal NK. Cholera: a great global concern. Asian Pac J Trop Med. 2011;4:573-80.
42. Speer BS, Shoemaker NB, Salyers AA. Bacterial Resistance to tetracycline: mechanisms, transfer and clinical significance. Clin Microbiol Rev. 1992;25:387-99.
43. Juliana MVB, Ronaldo MA, Irma NGR, Dalia PR, David KRK, Campos C. Prevalence of virulence-associated genes in clinical and environmental Vibrio cholerae strains isolated in Brazil between 1991 and 1999. FEMS Microbiol Lett. 2002;215:15-21.
44. Chen CH, Shimada T, Elhadi N, Radu S, Nishibushi M. Phenotypic and Genotypic characteristic and epidemiological significance of ctx + strains of Vibrio cholerae isolated from seafood in Malaysia. Appl Environ Microbiol. 2004;70:1964-72.
45. Chakraborty S, Mukhopadhyay AK, Bhadra RK, Ghosh AN, Mitra R, Shimada T, et al. Virulence genes in Environmental strains of Vibrio cholerae. Appl Environ Microbiol. 2000;66(9):4022-8.